Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20564411

Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2010 Jun 15
First author
Kushner BH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kushner BH
      type
      Author
    2. name
      Kramer K
      type
      Author
    3. name
      Modak S
      type
      Author
    4. name
      Qin LX
      type
      Author
    5. name
      Cheung NK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kushner BH
      type
      Author
    2. name
      Kramer K
      type
      Author
    3. name
      Modak S
      type
      Author
    4. name
      Qin LX
      type
      Author
    5. name
      Cheung NK
      type
      Author
    bibliography ids
    1. nci-bib-1f25335d5415f26442f2a917
    book metadata
    content sha256
    8122283eb1348df17f53ea7eec84bc6e86fa7ab954d300aae9a44271aad050e3
    document type
    citation
    dois
    1. 10.1002/cncr.25232
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20564411
    immutable id
    pubmed:20564411@8122283eb1348df17f53ea7eec84bc6e86fa7ab954d300aae9a44271aad050e3
    journal
    abbreviation
    Cancer
    issn electronic
    Source null
    issn print
    0008-543X
    issue
    12
    name
    Cancer
    nlm unique id
    0374236
    pages
    3054-60
    volume
    116
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20564411
      provenance
      batch id
      bce21fa556c206e375c2
      provider
      NCBI PubMed ESummary
      record sha256
      a6863a38f7f34d072f20a49b21ec6d4d7daa89d5e23b4422929a3f60db42fbd2
      response sha256
      280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
      retrieved at
      2026-09-09T23:46:33.526275+00:00
      publication date
      display
      2010 Jun 15
      precision
      day
      year
      2010
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20564411/
      title
      Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma.

      Preserved source evidence · Not medical advice